Prosecution Insights
Last updated: August 17, 2026

Examiner: MEYERING, SHABANA SHABBEER

Tech Center 4100 • Art Units: 1600 1635 1636 4100

This examiner grants 70% of resolved cases

Performance Statistics

69.7%
Allow Rate
+9.7% vs TC avg
119
Total Applications
+41.8%
Interview Lift
1092
Avg Prosecution Days
Based on 66 resolved cases, 2023–2026

Rejection Statute Breakdown

7.7%
§101 Eligibility
10.6%
§102 Novelty
35.0%
§103 Obviousness
32.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18141166 PROTECTING OLIGONUCLEOTIDES FOR CRISPR GUIDE RNA Non-Final OA UNIVERSITY OF MASSACHUSETTS
18590275 HBB-MODULATING COMPOSITIONS AND METHODS Final Rejection Flagship Pioneering Innovations VI, LLC
18577881 METHODS OF CONTROLLING RNA BINDING PROTEIN ACTIVITY Non-Final OA The Regents of the University of California
18467442 METHODS AND COMPOSITIONS FOR REJUVENATING CNS GLIAL POPULATIONS BY SUPPRESION OF TRANSCRIPTION FACTORS Final Rejection UNIVERSITY OF ROCHESTER
17701013 MULTI-INPUT MIRNA SENSING WITH CONSTITUTIVE ERNS TO REGULATE MULTI-OUTPUT GENE EXPRESSION IN MAMMALIAN CELLS Non-Final OA Massachusetts Institute of Technology
18026222 USE OF LONG NON-CODING RNAS IN MEDULLOBLASTOMA Non-Final OA UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC.
17766998 COMPOSITIONS AND METHODS FOR HOMOLOGY-DIRECTED RECOMBINATION Non-Final OA LIFE TECHNOLOGIES CORPORATION

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month